The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-9 of 9 articles
How should I treat a coronary artery to pulmonary artery fistula at an acute stent thrombosis site?
December 20, 2017 | 10.4244/EIJ-D-16-00903
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment
Pyxaras S,
Hunziker L,
Chieffo A,
Meliga E,
Latib A,
Park S,
Onuma Y,
Capranzano P,
Valgimigli M,
Narbute I,
Makkar R,
Palacios I,
Kim Y,
Buszman P,
Chakravarty T,
Sheiban I,
Mehran R,
Margey R,
Agnihotri A,
Marra S,
Capodanno D,
Leon M,
Moses J,
Fajadet J,
Lefèvre T,
Morice M,
Erglis A,
Tamburino C,
Alfieri O,
Serruys P,
Colombo A,
Naber C
August 5, 2016 | 10.4244/EIJV12I5A102
Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry
Meliga E,
De Benedictis M,
Chieffo A,
Latib A,
Park S,
Kim Y,
Onuma Y,
Capranzano P,
Jegere S,
Makkar R,
Palacios I,
Buszman P,
Bande M,
Chakravarty T,
Mehran R,
Naber C,
Scrocca I,
Margey R,
Leon M,
Moses J,
Fajadet J,
Lefèvre T,
Morice M,
Erglis A,
Tamburino C,
Alfieri O,
Conte M,
Serruys P,
Colombo A
November 29, 2013 | 10.4244/EIJV9I7A133
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.
Rodriguez A,
Maree A,
Tarragona S,
Fernandez-Pereira C,
Santaera O,
Granillo R,
Rodríguez-Granillo G,
Russo-Felssen M,
Kukreja N,
Antoniucci D,
Palacios I,
Serruys P
June 30, 2009 | 10.4244/EIJV5I2A40
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)
Meliga E,
Garcia-Garcia H,
Valgimigli M,
Chieffo A,
Biondi-Zoccai G,
O’ Maree A,
Gonzalo N,
Cook S,
Cruz-González I,
Marra S,
De Servi S,
Palacios I,
Windecker S,
van Domburg R,
Colombo A,
Sheiban I,
Serruys P
May 13, 2008
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial
Rodriguez A,
O’ Maree A,
Grinfeld L,
Fernandez-Pereira C,
Mieres J,
Alemparte MR,
Berrocal D,
Rodríguez-Granillo G,
Vigo C,
Felsen M,
O’ Neill W,
Palacios I
May 20, 2006
Latest news
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
AHEAD OF PRINT
Antiplatelet therapy following PCI for stable CAD
FREE ARTICLE - Anoop N. Koshy et al
January 19, 2023